GERN Insider Trading
Insider Ownership Percentage: 3.00%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $6,808,003.88
Geron Share Price & Price History
Current Price: $2.89
Price Change: ▼ Price Decrease of -0.03 (-1.03%)
As of 01/17/2025 05:00 PM ET
Geron Insider Trading History
Geron Institutional Trading History
Data available starting January 2016
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.
Read More on Geron
Volume
8,637,921 shs
Average Volume
12,673,040 shs
Market Capitalization
$1.75 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.55
Who are the company insiders with the largest holdings of Geron?
Geron's top insider shareholders include:
- John A Scarlett (CEO)
- Olivia Kyusuk Bloom (CFO)
- Elizabeth G O'farrell (Director)
- Andrew J Grethlein (COO)
- Faye Feller (EVP)
- John A Scarlett (CEO)
- Susan Molineaux (Director)
- V Bryan Lawlis (Director)
Learn More about top insider investors at Geron.
Who are the major institutional investors of Geron?
Geron's top institutional investors include:
- Hennion & Walsh Asset Management Inc. — 0.07%
- Moody National Bank Trust Division — 0.04%
- Inspire Investing LLC — 0.02%
- Elmwood Wealth Management Inc. — 0.00%
- Monterey Private Wealth Inc. — 0.00%
- Rovin Capital UT ADV — 0.00%
Learn More about top institutional investors of Geron stock.
Which major investors are selling Geron stock?
Within the last quarter, GERN stock was sold by these institutional investors:
- Inspire Investing LLC
In the previous year, company insiders that have sold Geron company stock include:
- John A Scarlett (CEO)
- Olivia Kyusuk Bloom (CFO)
- Elizabeth G O'farrell (Director)
Learn More investors selling Geron stock.
Which major investors are buying Geron stock?
During the previous quarter, GERN stock was acquired by institutional investors including:
- Moody National Bank Trust Division
- Hennion & Walsh Asset Management Inc.
- Elmwood Wealth Management Inc.
- Monterey Private Wealth Inc.
- Rovin Capital UT ADV